MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma
Status:
Recruiting
Trial end date:
2022-03-25
Target enrollment:
Participant gender:
Summary
This trial studies how well MoleMapper, Visiomed, and confocal microscopy work in screening
participants for melanoma. Analyzing images (photographs) made with three different portable
imaging systems may be as good as a visit to a dermatologist's office for finding melanomas
before they can spread.
Phase:
N/A
Details
Lead Sponsor:
OHSU Knight Cancer Institute
Collaborators:
National Cancer Institute (NCI) Oregon Health and Science University